Literature DB >> 24370446

Associated factors of estimated desaturase activity in the EPIC-Potsdam study.

K Schiller1, S Jacobs1, E Jansen2, C Weikert3, R di Giuseppe3, H Boeing3, M B Schulze1, J Kröger4.   

Abstract

BACKGROUND AND AIMS: Altered activity of desaturase enzymes may be involved in the development of metabolic diseases like type 2-diabetes. Desaturase activities might be modifiable by diet and lifestyle-related factors, but no study has systematically investigated such factors so far. We aimed to evaluate the association of demographic, anthropometric, dietary and lifestyle characteristics with estimated Δ5-, Δ6- and Δ9-desaturase activity. METHODS AND
RESULTS: A subsample (n = 1782) of the EPIC-Potsdam study was used for a cross-sectional analysis, involving men and women, mainly aged 35-65 years. Fatty acid (FA) product-to-precursor ratios, derived from the FA composition of erythrocyte membrane phospholipids, were used to estimate desaturase activities. Multiple linear regression models were used with estimated Δ5-, Δ6- and Δ9-desaturase activity as outcome and demographic (age, sex), anthropometric (BMI, WHR), dietary intake (FAs, carbohydrates) and lifestyle (physical activity, smoking, alcohol consumption) factors as exposure variables. Alcohol intake was positively associated with estimated Δ6- (explained variance in desaturase activity: 1.52%) and estimated Δ9-desaturase activity (explained variance: 5.53%). BMI and WHR showed a weak inverse association with estimated Δ5-desaturase activity (explained variance: BMI: 1.07%; WHR: 1.02%) and weak positive associations with estimated Δ6-(explained variance: BMI: 1.17%; WHR: 1.19%) and estimated Δ9-desaturase activities (explained variance: BMI: 0.70%; WHR: 0.96%). Age, sex, physical activity, smoking and dietary factors were only weakly associated with the estimated desaturase activities.
CONCLUSION: Our findings suggest that alcohol intake as well as obesity measures are associated with the FA ratios reflecting desaturase activity.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diet; Lifestyle; Obesity; Δ5-desaturase; Δ6-desaturase; Δ9-desaturase

Mesh:

Substances:

Year:  2013        PMID: 24370446     DOI: 10.1016/j.numecd.2013.10.029

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk.

Authors:  Harvey J Murff; Todd L Edwards
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-12-01

2.  Association of serum fatty acid and estimated desaturase activity with hypertension in middle-aged and elderly Chinese population.

Authors:  Bo Yang; Fang Ding; Feng-Lei Wang; Jing Yan; Xiong-Wei Ye; Wei Yu; Duo Li
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

3.  Serum Phospholipid Fatty Acids Levels, Anthropometric Variables and Adiposity in Spanish Premenopausal Women.

Authors:  María Del Pilar Del Pozo; Virginia Lope; Inmaculada Criado-Navarro; Roberto Pastor-Barriuso; Nerea Fernández de Larrea; Emma Ruiz; Adela Castelló; Pilar Lucas; Ángeles Sierra; Isabelle Romieu; Véronique Chajès; Feliciano Priego-Capote; Beatriz Pérez-Gómez; Marina Pollán
Journal:  Nutrients       Date:  2020-06-25       Impact factor: 5.717

4.  Plasma Phospholipid n-3/n-6 Polyunsaturated Fatty Acids and Desaturase Activities in Relation to Moderate-to-Vigorous Physical Activity through Pregnancy: A Longitudinal Study within the NICHD Fetal Growth Studies.

Authors:  Liwei Chen; Yeyi Zhu; Zhe Fei; Stefanie N Hinkle; Tong Xia; Xinyue Liu; Mohammad L Rahman; Mengying Li; Jing Wu; Natalie L Weir; Michael Y Tsai; Cuilin Zhang
Journal:  Nutrients       Date:  2020-11-19       Impact factor: 5.717

5.  Is There a Link between Zinc Intake and Status with Plasma Fatty Acid Profile and Desaturase Activities in Dyslipidemic Subjects?

Authors:  Marija Knez; Ana Pantovic; Milica Zekovic; Zoran Pavlovic; Maria Glibetic; Manja Zec
Journal:  Nutrients       Date:  2019-12-28       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.